CeCors, Inc.CC

CeCors, Inc.

0.0055USDD
−0.0011−16.67%
At close at Mar 27, 19:04 GMT
USD
No trades
See on Supercharts

CEOS fundamentals

Key facts

Market capitalization‪70.77 K‬USD
Basic EPS (TTM)−0.00USD
Founded2002
CEOMichael Maher
Website
About

CeCors, Inc. manufactures and distributes healthcare supplies and healthcare equipment. It also engages in the acquisition and development of healthcare companies for the healthcare supplies and healthcare equipment markets. The company was founded on April 16, 2002 and is headquartered in Etobicoke, Canada.

Ownership
‪‪12.87 M‬‬
Free Float shares
‪‪6.75 M‬‬ (52.42%)
Closely held shares
‪‪6.12 M‬‬ (47.58%)
Free Float shares
‪‪6.75 M‬‬ (52.42%)
Closely held shares
‪‪6.12 M‬‬ (47.58%)
Capital structure
Market cap
‪‪70.77 K‬‬
Debt
‪‪1.11 M‬‬
Minority interest
‪787.00‬
Preferred stock
‪‪2.55 K‬‬
Cash & equivalents
‪‪1.05 M‬‬
Enterprise value
‪‪134.70 K‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪70.77 K‬‬
Price to earning ratio (P/E)
Price to sales ratio (P/S)
0.93x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
Price to sales ratio (P/S)
0.93x
Valuation ratios
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
‪50.00‬
‪100.00‬
‪150.00‬
‪200.00‬
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−326%‬
‪−246%‬
‪−166%‬
‪−86%‬
‪−6%‬
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪‪−1.40 M‬‬
‪‪−700.00 K‬‬
‪0.00‬
‪‪700.00 K‬‬
‪‪1.40 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−500.00 K‬‬
‪0.00‬
‪‪500.00 K‬‬
‪‪1.00 M‬‬
‪‪1.50 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−500.00 K‬‬
‪0.00‬
‪‪500.00 K‬‬
‪‪1.00 M‬‬
‪‪1.50 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Vetcomm
PsyKey and Corporate
By country
Period: 2023
United States

Dividends

Dividend yield, history and sustainability

CEOS does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
‪‪450.00 K‬‬
‪‪900.00 K‬‬
‪‪1.35 M‬‬
‪‪1.80 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪800.00 K‬‬
‪‪1.60 M‬‬
‪‪2.40 M‬‬
‪‪3.20 M‬‬
Assets
Liabilities